Stephen Wolverton

  • 291 Citations
  • 10 h-Index
1985 …2019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1985 2019

  • 291 Citations
  • 10 h-Index
  • 23 Article
  • 3 Chapter
  • 1 Review article
Filter
Article
34 Citations (Scopus)

A survey of resident perceptions of effective teaching behaviors.

Wolverton, S. & Bosworth, M. F., May 1985, In : Family Medicine. 17, 3, p. 106-108 3 p.

Research output: Contribution to journalArticle

Family Practice
Teaching
Clinical Competence
Medical Education
Statistical Factor Analysis
4 Citations (Scopus)

Can short courses of systemic corticosteroids truly cause osteonecrosis?

Wolverton, S., Sep 2009, In : Dermatologic Therapy. 22, 5, p. 458-464 7 p.

Research output: Contribution to journalArticle

Osteonecrosis
Adrenal Cortex Hormones
Necrosis
Systemic Lupus Erythematosus
Curriculum
7 Citations (Scopus)

Dermatologic drug formulary: An American Academy of Dermatology white paper

Steger, J. W., Wolverton, S., Greenberg, R. D., Ling, M. R., Resnick, S. D. & James, W. D., Jan 1996, In : Journal of the American Academy of Dermatology. 34, 1, p. 99-109 11 p.

Research output: Contribution to journalArticle

Pharmaceutical Preservatives
Dermatologic Agents
Hospital Formularies
Pharmacy and Therapeutics Committee
Formularies
7 Citations (Scopus)

Drug hypersensitivity syndrome in a patient receiving vismodegib

Lam, T., Wolverton, S. & Davis, C. L., Mar 2014, In : Journal of the American Academy of Dermatology. 70, 3

Research output: Contribution to journalArticle

HhAntag691
Local Neoplasm Recurrences
Drug Hypersensitivity Syndrome
Anilides
Pyridines
22 Citations (Scopus)
Muir-Torre Syndrome
Immunosuppressive Agents
Immunosuppression
Mutation
DNA Mismatch Repair
24 Citations (Scopus)

Important controversies associated with isotretinoin therapy for acne

Wolverton, S. & Harper, J. C., Apr 2013, In : American Journal of Clinical Dermatology. 14, 2, p. 71-76 6 p.

Research output: Contribution to journalArticle

Isotretinoin
Acne Vulgaris
Depression
Therapeutics
Pregnancy
2 Citations (Scopus)

Introduction: Controversies in dermatologic drug therapy

Wolverton, S., Sep 2009, In : Dermatologic Therapy. 22, 5, p. 397 1 p.

Research output: Contribution to journalArticle

Dermatologic Agents
Risk Management
Dermatology
Decision Making
Drug Therapy
10 Citations (Scopus)

Major adverse effects from systemic drugs: Defining the risks

Wolverton, S., 1995, In : Current Problems in Dermatology (United States). 7, 1, p. 6-38 33 p.

Research output: Contribution to journalArticle

Adrenal Cortex Hormones
Pancytopenia
Agranulocytosis
Fatal Outcome
Retinoids
1 Citation (Scopus)

Medical Malpractice in Dermatology—Part I: Reducing the Risks of a Lawsuit

Shah, V. V., Kapp, M. B. & Wolverton, S., Dec 1 2016, In : American Journal of Clinical Dermatology. 17, 6, p. 593-600 8 p.

Research output: Contribution to journalArticle

Malpractice
Risk Management
Physicians
Electronic Health Records
Jurisprudence

Medical Malpractice in Dermatology—Part II:  What To Do Once You Have Been Served with a Lawsuit

Shah, V. V., Kapp, M. B. & Wolverton, S., Dec 1 2016, In : American Journal of Clinical Dermatology. 17, 6, p. 601-607 7 p.

Research output: Contribution to journalArticle

Malpractice
Physicians
Risk Management
Jurisprudence
Anxiety
25 Citations (Scopus)

Monitoring for adverse effects from systemic drugs used in dermatology

Wolverton, S., 1992, In : Journal of the American Academy of Dermatology. 26, 5 I, p. 661-679 19 p.

Research output: Contribution to journalArticle

Dermatology
Pharmaceutical Preparations
Patient Participation
Dapsone
Retinoids
8 Citations (Scopus)

Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis

Weaver, C. H., Huddleston, H. M., Kingsley, M. & Wolverton, S., Nov 2009, In : Journal of drugs in dermatology : JDD. 8, 11, p. 1031-1033 3 p.

Research output: Contribution to journalArticle

Drug Hypersensitivity Syndrome
Stevens-Johnson Syndrome
Drug Eruptions
Drug Hypersensitivity
Eating
3 Citations (Scopus)

Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate

Veerula, V. L., Ezra, N., Aouthmany, M., Graham, T. A., Wolverton, S. & Somani, A-K., 2016, In : Cutis. 98, 6, p. E12-E15

Research output: Contribution to journalArticle

Keratoacanthoma
Methotrexate
Wounds and Injuries
Cicatrix
Skin
4 Citations (Scopus)

Optimizing clinical use of azathioprine with newer pharmacogenetic data

Wolverton, S., Jun 2009, In : Archives of Dermatology. 145, 6, p. 707-710 4 p.

Research output: Contribution to journalArticle

Drug Dose Response Relationship
Drug Administration Schedule
Vesiculobullous Skin Diseases
Maximum Tolerated Dose
Pharmacogenetics
1 Citation (Scopus)

Pemphigus foliaceus with epidermal detachment: Adverse events from patch testing

Cocklin, C. L., Shackelford, K., Wolverton, S. & Fett, D. D., Mar 2006, In : Dermatitis. 17, 1, p. 32-35 4 p.

Research output: Contribution to journalArticle

Pemphigus
Skin

Pyoderma gangrenosum: A presenting sign of myelodysplastic syndrome in undiagnosed fanconi anemia

Kandula, P., Shah, K. M., Wolverton, J. E., Le, C. & Wolverton, S., Jan 1 2019, In : Dermatology Online Journal. 25, 1

Research output: Contribution to journalArticle

Pyoderma Gangrenosum
Fanconi Anemia
Myelodysplastic Syndromes
Ear
Bone Marrow
61 Citations (Scopus)

Recent trends in systemic psoriasis treatment costs

Beyer, V. & Wolverton, S., Jan 2010, In : Archives of Dermatology. 146, 1, p. 46-54 9 p.

Research output: Contribution to journalArticle

Psoriasis
Health Care Costs
Costs and Cost Analysis
Economic Inflation
Names
20 Citations (Scopus)

Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs

Wolverton, S. & Remlinger, K., Apr 2007, In : Dermatologic Clinics. 25, 2, p. 195-205 11 p.

Research output: Contribution to journalArticle

Physiologic Monitoring
Guidelines
Dapsone
Liver
Azathioprine
6 Citations (Scopus)

Systemic Drug Therapy for Psoriasis: The Most Critical Issues

Wolverton, S., 1991, In : Archives of Dermatology. 127, 4, p. 565-568 4 p.

Research output: Contribution to journalArticle

Cyclosporins
Hydroxyurea
Psoriasis
Methotrexate
Drug Therapy
21 Citations (Scopus)

The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.

Allen, K. J. & Wolverton, S., Sep 2007, In : Journal of drugs in dermatology : JDD. 6, 9, p. 883-889 7 p.

Research output: Contribution to journalArticle

Pemphigus
Safety
CD20 Antigens
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
19 Citations (Scopus)

The Muir-Torre syndrome in a black patient with AIDS: Histopathology and molecular genetic studies

Warschau, K. E., Eble, J., Hood, A. F., Wolverton, S. & Halling, K. C., 1997, In : Journal of Cutaneous Pathology. 24, 8, p. 511-518 8 p.

Research output: Contribution to journalArticle

Muir-Torre Syndrome
Molecular Biology
Acquired Immunodeficiency Syndrome
Adenocarcinoma
Microsatellite Instability

Top-accessed article: Topical rapamycin

Haggstrom, A. & Wolverton, S., Feb 2013, In : JAMA Dermatology. 149, 2, p. 203 1 p.

Research output: Contribution to journalArticle

Sirolimus
11 Citations (Scopus)

Update on cutaneous drug reactions.

Wolverton, S., 1997, In : Advances in Dermatology. 13, p. 65-84 20 p.

Research output: Contribution to journalArticle

Histamine H2 Antagonists
Drug Eruptions
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proton Pumps
Calcium Channel Blockers